For families managing type 1 diabetes in children, the school-versus-holiday divide has long represented a practical anxiety: does the structure of the classroom protect glucose stability, or does the freedom of holidays? New real-world data from continuous glucose monitoring suggest the question may be largely moot when an automated insulin delivery system is in the loop — and the finding has meaningful implications for how clinicians counsel families about lifestyle flexibility.
This retrospective analysis tracked 55 children and adolescents aged 6–19 with type 1 diabetes who had used open-source Android Artificial Pancreas Systems (AAPS) for at least three months. Continuous glucose monitoring data were stratified into school-day and holiday periods and assessed across ten glycaemic metrics, including time in range (TIR), time in tight range (TITR), time above range (TAR), time below range (TBR), and coefficient of variation (CV). Across whole-day, daytime, and nighttime windows, none of these metrics differed significantly between school days and holidays (all p > 0.05). One standout finding emerged from multivariable regression: longer nighttime sleep duration during school days was independently associated with achieving both higher TITR (adjusted OR 2.29) and TIR (adjusted OR 2.07), pointing to sleep quality as an underappreciated lever for glycaemic optimization even within automated systems.
The broader significance here is architectural. Earlier-generation insulin pump therapy required consistent user input and was far more sensitive to schedule disruptions. The AAPS platform's closed-loop automation appears to absorb much of the variability that previously destabilized control during unstructured holiday periods. That said, this study carries notable limitations: the 55-participant cohort is small, the design is observational rather than randomized, and self-selection bias is likely since families adopting open-source APS tend to be highly engaged and technically proficient. The sleep finding, while biologically plausible given glucose regulation's circadian dependence, needs replication in larger, more diverse samples. Still, for clinicians and caregivers, this is an incrementally reassuring signal that modern closed-loop systems may genuinely flatten the glycaemic impact of routine life transitions.